Bio-Rad Laboratories, Inc. (BIO/B)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Bio-Rad Laboratories, Inc. (BIO/B)
Go deeper and ask any question about BIO/B
Company Performance
Current Price
as of Sep 13, 2024$326.74
P/E Ratio
N/A
Market Cap
$9.08B
Description
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Metrics
Overview
- HQHercules, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBIO/B
- Price$326.740.00%
Trading Information
- Market Cap$9.08B
- Float0.38%
- Average Daily Volume (1m)13
- Average Daily Volume (3m)21
- EPS-$47.00
Company
- Revenue$2.56B
- Rev Growth (1yr)-6.26%
- Net Income-$2.17B
- Gross Margin55.71%
- EBITDA Margin23.01%
- EBITDA$146.90M
- EV$7.56B
- EV/Revenue2.95
- P/EN/A
- P/S3.59